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Kallikrein-related peptidase 4 (KLK4) is a glycosylated
serine protease that is expressed speciﬁcally by matura-
tion-stage ameloblasts (1, 2), with only trace or very low
levels of expression in other tissues (3). Klk4 null mice
have undermineralized enamel, with no apparent eﬀects
elsewhere in the body (4). A premature termination co-
don in both human KLK4 alleles causes a recessive
hypomaturation form of amelogenesis imperfecta, with
no systemic abnormalities (5). Therefore, the structural
and functional features of KLK4 are presumed to be
adapted to its role in the maturation of dental enamel.
When KLK4 is not expressed during tooth develop-
ment, the enamel layer achieves normal thickness and
mineral architecture, with decussating enamel rods (4).
The enamel, however, retains enamel proteins and is
progressively less mineralized with depth, so that the
surface enamel is 8%, the middle enamel 15%, and the
deepest enamel about 20% less mineralized than normal
(6). Following eruption, the enamel rapidly fractures in
the deep enamel just above the dentino–enamel junction
(7). At present it is unclear how the surface enamel,
without KLK4 to digest the accumulated enamel pro-
teins, hardens to the extent observed in Klk4 null mice. It
appears that superﬁcial proteins are readily reabsorbed
into ameloblasts by endocytosis, and KLK4 cleavages
are required to increase the rate and ease with which
protein fragments return to the enamel surface for
reabsorption. The activity of membrane-bound or other
secreted proteases in maturation-stage enamel has not
been excluded, but should such accessory activity exist it
is increasingly unable to compensate for the absence of
KLK4 with distance from the ameloblast.
The activated human, pig, and mouse KLK4 enzymes
all have 224 amino acids reinforced with six disulﬁde
bridges. Pig and mouse KLK4 contain three potential N-
glycan attachment sites (pig at Asn104, Asn139, and
Asn184; and mouse at Asn93, Asn139, and Asn184).
Human KLK4 has only one potential N-glycan attach-
ment site (at Asn139). Recombinant human KLK4 ex-
pressed in bacteria is not glycosylated, is active, and its
crystal structure has been determined (8). Human and
mouse KLK4 have never been isolated from natural
sources and their glycosylation status is unknown. Pig
KLK4 is heavily glycosylated, and deglycosylation cau-
ses it to lose activity (9), although its three potential
N-linked glycosylation sites are on the back of the en-
zyme, away from its active site (10).
In general, glycosylation is an important structural
and functional feature that inﬂuences the physicochem-
ical properties of proteins, such as conformational sta-
bility and solubility, protects them from proteolysis, and
can aﬀect protein–protein and protein–mineral inter-
actions (11, 12). There are currently 16 known inher-
ited glycosylation disorders caused by defects in the
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Kallikrein-related peptidase 4 (KLK4) is a glycosylated serine protease that functions
in the maturation (hardening) of dental enamel. Pig and mouse KLK4 contain three
potential N-glycosylation sites. We isolated KLK4 from developing pig and mouse
molars and characterized their N-glycosylations. N-glycans were enzymatically re-
leased by digestion with N-glycosidase F and ﬂuorescently labeled with 2-aminoben-
zoic acid. Normal-phase high-performance liquid chromatography (NP-HPLC)
revealed N-glycans with no, or with one, two, or three sialic acid attachments in pig
KLK4 and with no, or with one or two sialic acid attachments in mouse KLK4. The
labeled N-glycans were digested with sialidase to generate the asialo N-glycan cores
that were fractionated by reverse-phase HPLC, and their retention times were com-
pared with similarly labeled glycan standards. The puriﬁed cores were characterized by
mass spectrometric and monosaccharide composition analyses. We determined that
pig and mouse KLK4 have NA2 and NA2F biantennary N-glycan cores. The pig
triantennary core is NA3. The mouse triantennary core is NA3 with a fucose con-
nected by an a1-6 linkage, indicating that it is attached to the ﬁrst N-acetyglucosamine
(NA3F). We conclude that pig KLK4 has NA2, NA2F, and NA3 N-glycan cores with
no, or with one, two, or three sialic acids. Mouse KLK4 has NA2, NA2F, and NA3F
N-glycan cores with no, or with one or two sialic acids.
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N-glycosylation pathway that cause severe protein hy-
poglycosylation diseases with multisystemic phenotypes
and neurological impairment (13, 14). In this study we
characterized the N-glycans attached to pig and mouse
KLK4.
Material and methods
All experimental procedures involving the use of animals
were reviewed and approved by the Institutional Animal
Care and Use Program at the University of Michigan.
Sequence analysis
Human (NM_004917.3), mouse (NM_019928.1), and pig
(NM_213802.1) KLK4 protein sequences were retrieved
from the National Center for Biotechnology Information
(NCBI) and aligned manually. Potential N-glycosylation
sites were identiﬁed using NetNGlyc 1.0 linked to the Expert
Protein Analysis System (ExPASy) proteomics server of the
Swiss Institute of Bioinformatics (SIB).
Isolation of KLK4
Recombinant human KLK4 zymogen (pro-KLK4) was
purchased from R&D Systems (Minneapolis, MN, USA).
Porcine KLK4 was extracted and puriﬁed from the second
molars of 6-month-old pigs, as described previously (15). In
brief, the hard enamel was extracted with neutral buﬀer and
subjected to a series of ammonium sulfate precipitations. The
40–65% saturation pellet was resuspended in 0.5 M acetic
acid and fractionated by reverse-phase high-performance
liquid chromatography (RP-HPLC). Mouse KLK4 was
isolated from the ﬁrst molars of 11-d-old mice. The dental
pulp tissue was removedwith tissue forceps, and then 50 teeth
were demineralized by incubation in 3 ml of 0.17 MHCl and
0.95% formic acid containing Protease Inhibitor Cocktail
Set III [1 mM 4-(2-aminoethyl) benzenesulfonyl ﬂuoride
hydrochloride (AEBSF), 0.8 lM aprotinin, 50 lM bestatin,
15 lM E-64, 20 lM leupeptin, and 10 lM pepstatin; Cal-
biochem, San Diego, CA, USA] and 1 mM 1,10-phenan-
throline for 2 h at 4C. This solution was neutralized by
dialysis against 1 l of 50 mM Tris–HCl buﬀer (pH 7.4)
containing the same protease inhibitors for 3 h at room
temperature and centrifuged for 10 min at 20,000 g at room
temperature. The supernatant was directly injected onto a
C18 reverse-phase column (Discovery C18, 4.6 mm ·
25 cm; Supelco, Bellefonte, PA, USA). The column was
eluted with a linear gradient (20–75%buﬀer B in 55 min) at a
ﬂow rate of 0.8 ml min)1. Buﬀer A was 0.05% triﬂuoroacetic
acid (TFA); buﬀer B was 0.5% TFA in 80% aqueous ace-
tonitrile. Proteins were detected by absorbance at 220 nm.
SDS-PAGE, western blots, and zymography
MouseKLK4 anti-peptide Igs were raised against the amino-
acid segments #85–99 C-HNLKGSQEPGSRMLE (Residue
‘‘C-’’ is added to conjugate the synthesized peptide to KLH
to enhance antigenicity and is not part of the KLK4 peptide)
and #187–202 YHLSMFCAGGGQDQKD and aﬃnity
puriﬁed on columns containing the immobilized peptides
(Yenzyme Antibodies, San Francisco, CA, USA). Pig,
mouse, and recombinant human KLK4 enzymes were
separated by SDS-PAGE on Tris-glycine gels stained with
Coomassie Brilliant Blue (CBB; Invitrogen, Carlsbad, CA,
USA). Duplicate gels were transblotted onto Hybond-ECL
membrane (GE Healthcare Bio-Sciences, Piscataway, NJ,
USA) and immunostained with polyclonal antibodies raised
in rabbits against recombinant pig KLK4 (16) or mouse
KLK4 anti-peptide Igs, or a commercially available N-ter-
minal KLK4 antibody (Abcam, Cambridge, MA, USA).
Zymography was performed using Novex 12% casein zymo-
gels (Invitrogen), incubated in 50 mM Tris-HCl/10 mM
EDTA containing 1 mM 1,10-phenanthrolin buﬀer (pH 7.4)
at 37C for 48 h.
Deglycosylation of KLK4 and labeling the N-glycans
PNGase F releases N-linked oligosaccharides from aspara-
gine residues (17). N-glycans were enzymatically released
from 2–3 lg of puriﬁed porcine or mouse KLK4 by incu-
bation with 1 mU of N-glycosidase F (PNGase F; QA-bio,
Palm Desert, CA, USA) in 50 mM sodium phosphate buﬀer
(pH 7.5) at 37C for 20 h. The porcine 32-kDa enamelin
(90 lg) was digested as a positive control. The released
N-glycans were fractionated by adding three volumes of
ice-cold ethanol and the deglycosylated proteins were pre-
cipitated by centrifugation for 10 min at 14,000 g. The N-
glycans in the supernatants were evaporated and labeled
with 2-aminobenzoic acid (2-AA, 137.14 g mol)1) using a 2-
AA labeling kit and S Cartridge (QA-bio). A labeled N-
glycan standard (10 pmol; NA2F glycan; QA-bio) and the
2-AA glycans were separated by size exclusion-HPLC (SE-
HPLC) using a Nanoﬁlm-SEC 150 column (7.8 mm · 30 cm;
Sepax Technologies, Newark, DE, USA) equilibrated with
PBS (135 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4,
1.4 mM Na2H2PO4; pH 7.3) and eluted with the same
solution at a ﬂow rate of 1.0 ml min)1 at room temperature.
The eﬄuent was continuously monitored by a ﬂuorescence
monitor (FP-2020; JASCO, Tokyo, Japan) using an exci-
tation wavelength of 320 nm and an emission wavelength of
420 nm. The amount of labeled N-glycans released was
determined by comparing the area under its chromato-
graphic peak with the labeled NA2F glycan standard (QA-bio).
Characterization of KLK4 N-glycans
Each of the 2-AA-labeled N-glycans (100 pmol) obtained
from SE-HPLC was further separated by normal-phase
(NP-HPLC) using a Supelcosil LC-NH2 column
(4.6 mm · 25 cm; Supelco, Bellefonte, PA, USA). The
column was eluted with a linear gradient (30–95% buﬀer B
in 97.5 min) at a ﬂow rate of 1.0 ml min)1. Buﬀer A was 2%
acetic acid/1% tetrahydrofuran in 100% acetonitrile and
buﬀer B was 5% acetic acid/1% tetrahydrofuran/3% tri-
ethylamine in water. The eﬄuent was continuously moni-
tored by a ﬂuorescence monitor using an excitation
wavelength of 320 nm and an emission wavelength of
420 nm. The 2-AA-labeled N-glycans were collected and
lyophilized. A set of 2-AA-labeled N-glycan standards
having no-, mono-, di- and tri-sialic acid at the terminal
position on their structures (NA2, A1, A2, and A3)
(QA-bio), were also fractionated by NP-HPLC under the
same conditions and their elution times were noted.
Isolation of KLK4 core-N-glycans
Core N-glycans were obtained by enzymatic removal
of sialic acid. Each of the 2-AA-labeled N-glycans was
incubated with 10 mU of sialidase Au (QA-bio) in 50 mM
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sodium phosphate buﬀer (pH 6.0) for 3 h at 37C. The
reaction mixture was separated by NP-HPLC, as described
above. The asialo-fraction (KLK4 core N-glycans) was
collected and lyophilized. This sample was fractionated by
RP-HPLC using a GlycoSep R column (4.6 mm · 15 cm;
ProZyme, Hayward, CA, USA), and eluted with a linear
gradient (5–95% buﬀer B in 50 min) at a ﬂow rate of
0.6 ml min)1. Buﬀer A was 50 mM ammonium acetate
buﬀer (pH 6.0) and buﬀer B was 50 mM ammonium acetate
in 8% acetonitrile. The eﬄuent was continuously monitored
by a ﬂuorescence monitor using an excitation wavelength of
320 nm and an emission wavelength of 420 nm. The struc-
tures of KLK4 core N-glycans were determined by com-
paring their retention times with those of the 2-AA
N-glycan standards (NA2, NA2F, and NA3; QA-bio). The
KLK4 core N-glycans were collected, lyophilized, and used
for mass spectrometric and monosaccharide composition
analyses. An aliquot of the KLK4 core N-glycan sample that
did not have a retention time which matched the standards
(peak d) was digested with 1 mU of a-(1-6) fucosidase (QA-
bio) in 50 mM sodium phosphate buﬀer (pH 5.0) for 20 h at
37C. The reaction mixture was separated by RP-HPLC
using a GlycoSep R column and compared with a retention
time of 2-AA N-glycan standards, as described above.
Mass spectrometry
Matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF-MS) was performed by
W.M. Keck Biotechnology Resource Laboratory at Yale
University (New Haven, CT, USA) on puriﬁed KLK4 core-
N-glycans.
Monosaccharide analysis of KLK4 core N-glycans
The monosaccharide compositions of each KLK4 core
N-glycan were determined by digesting each N-glycan into its
component monosaccharides and labeling the released
monosaccharides with 2-AA, using the 2-AAMonosaccharide
Release and Labeling Kit (QA-bio), and fractionating by RP-
HPLC. The identity of each monosaccharide was determined
by comparing its retention time with 2-AA-labeled mono-
saccharide standards. The amount of each monosaccharide
was determined by calculating the area under its chromato-
graphic peak and normalizing against the mannose peak, as
there are predictably three mannoses per N-glycan. Each
puriﬁed KLK4 core N-glycan was hydrolyzed with a mixture
of equal volumes of 2 M TFA and 6 MHCl at 100C for 3 h.
The solution was diluted with the water and lyophilized. The
dried sample and a monosaccharide mixed standard
(100 pmol) were labeled with 2-AA at 80C for 45 min. The
reaction mixture was diluted with the water and was applied
onto a GlycoSep R column (4.6 mm · 15 cm; ProZyme). The
column was eluted with the second step of the gradient (7–
27% buﬀer B in 28 min and 27–100% B in 2 min) at a ﬂow
rate of 0.6 ml min)1. Buﬀer A was 0.2% butylamine/0.5%
phosphoric acid/1% tetrahydrofuran and buﬀer B was 50%
buﬀer A in 50% acetonitrile. The eﬄuent was continuously
monitored by a ﬂuorescence monitor using an excitation
wavelength of 360 nm and an emission wavelength of 425 nm.
Results
The ﬁrst objective was to isolate pig, mouse, and human
KLK4. Pig and mouse KLK4 fractions from developing
teeth were puriﬁed by RP-HPLC, and appeared as single
chromatographic peaks (Fig. 1A). The puriﬁed KLK4
proteases were characterized by SDS-PAGE, casein
zymography, and western blotting (Fig. 1B). In the
quantities applied KLK4 did not stain with CBB, but
was readily visible on zymograms and western blots. No
other protein bands besides albumin (at 57 kDa) were
observed in the CBB-stained gels. Albumin is a common
contaminant in KLK4 preparations, but was not a
concern in this study because it is not glycosylated. These
analyses suggested that KLK4 was well puriﬁed and
unlikely to be contaminated with glycoproteins. Pig
KLK4 was detected as a doublet at 30 and 34 kDa,
mouse KLK4 at 24 and 29 kDa, and thermolysin-acti-
vated recombinant human KLK4 (which contains a
C-terminal His tag) as a smear between 26 and 29 kDa.
The presence of multiple KLK4 bands is probably
caused by variations in glycosylation (9). Commercially
available recombinant human KLK4 was our only
source of the human protease, but this recombinant
protein did not appear to be glycosylated (there was no
change in mobility on SDS-PAGE following deglycosy-
lation) and so no further characterization of re-
combinant human KLK4 was attempted.
The pig and mouse KLK4 enzymes were deglycosy-
lated, and the released N-glycans were ﬂuorescently
labeled with 2-AA (Fig. 1C) and fractionated by NP-
HPLC along with similarly labeled glycan standards,
which revealed signiﬁcant heterogeneity in their degrees
of sialylation (Fig. 2). Pig KLK4 contained N-glycans
with no, or one, two or three sialic acids per N-glycan;
mouse KLK4 N-glycans contained no, or one or two
sialic acids per molecule (N-glycans with three sialic
acids were not detected in mouse KLK4). Knowing this,
the released N-glycans were reduced to their glycan
cores by enzymatic removal of all sialic acid, which was
conﬁrmed by fractionation of the sialidase digestion
products by NP-HPLC (Fig. 3A). The desialylated
2-AA-labeled N-glycan cores were resolved by RP-
HPLC and their retention times were compared with
2-AA-labeled N-glycan standards (Fig. 3B). Three pig
N-glycan cores were observed (designated a, b, and c),
which had identical retention times to the N-glycan
standards NA2, NA3, and NA2F, respectively. Three
mouse N-glycan cores were also observed. Two
(a = NA2 and c = NA2F) were the same as those in
pig. The third (designated d) was digested by a-(1-6)
fucosidase, which shifted its retention time to match N-
glycan core b (Fig. 3C), indicating that core d was like
b, but also contained fucose connected by an a-(1-6)
bond, which localizes its attachment to the ﬁrst N-acet-
ylglucosamine (GlcNAc) in the N-glycan.
Aliquots of the four (a–d) N-glycan cores were
hydrolyzed into their monosaccharide components. The
labeled monosaccharides from each N-glycan core were
fractionated by RP-HPLC and their retention times were
compared with those of labeled monosaccharide stan-
dards, which identiﬁed the monosaccharides within each
N-glycan core (Fig. 4A). By determining the areas under
each chromatographic peak and normalizing to three
mannoses per N-glycan core, we calculated the number
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of each type of monosaccharide in each N-glycan core.
Depolymerizing the N-glycans into monosaccharides
deacetylates GlcNAc into glucosamine (GlcN), so these
monosaccharides cannot be distinguished by this analy-
sis. For independent veriﬁcation of the compositions and
clariﬁcation of the GlcN/GlcNAc ambiguity, aliquots of
the four 2-AA-labeled N-glycan cores were sent for mass
determination (Fig. 4B). In each case the monosaccha-
ride compositions and the N-glycan cores they suggested
were strongly supported by the mass analyses, with the
diﬀerence between the expected and predicted masses
being smaller than half a dalton (Fig. 4C). The mass
analyses showed that all of the GlcN observed in the
monosaccharide composition analyses was derived from
GlcNAc.
The positions of the predicted N-linked glycosylation
sites on pig and mouse KLK4, along with the structures
of the four N-glycan chains that modify them, are shown
in Fig. 5. The diﬀerences between the N-glycan attach-
ments for pig and mouse KLK4 are minor. Both en-
zymes contain three diﬀerent N-glycan cores. The
biantennary N-glycan cores (NA2, NA2F) are same in
pig and mouse KLK4. The third core is triantennary,
and shows only minor diﬀerences between pig and
mouse. The mouse triantennary structure (NA3F) con-
tains a single fucose attached to the GlcNAc at its base,
while the pig structure (NA3) lacks this fucose.
Discussion
This is the ﬁrst isolation of mouse KLK4 from in vivo
sources and structural characterization of KLK4 gly-
cosylations. The active pig and mouse KLK4 proteases
have the same number of amino acids (n = 224) and
similar calculated molecular mass values (pig = 24,117
Da; mouse = 24,179 Da) and isoelectric points (pig =
4.75; mouse = 5.54). The pig and mouse enzymes show
some diﬀerences in substrate speciﬁcity: pig KLK4 is
more visible on gelatin zymograms; mouse KLK4 is
stronger on casein zymograms. Both enzymes are
Fig. 1. Isolation of pig and mouse kallikrein-related peptidase
4 (KLK4) and initial characterization of pig, mouse, and re-
combinant human KLK4. (A) (left to right) Reverse-phase high
performance liquid chromatography (RP-HPLC) chromato-
grams of pig neutral extract, 40–65% ammonium sulfate pre-
cipitate; pig KLK4 fraction collected at 54 min (arrowhead);
mouse acid extract; and KLK4 fraction collected at 54 min
(arrowhead). The y-axes represent 10 · the absorbance at
220 nm and the x-axes represent minutes from injection of
sample. (B) (left to right) Characterization of pig, mouse, and
recombinant human KLK4 samples used for N-glycan analy-
ses. All gels: lane 1, SDS-polyacrylamide gel stained with
Coomassie Brilliant Blue; lane 2, casein zymograms showing
enzyme activity; lane 3, western blots probed with KLK4
antibodies. (C) Size-exclusion chromatograms of 2-aminoben-
zoic acid (2-AA)-labeled N-glycans (arrowheads) being sepa-
rated from excess label. The y-axes represent 100 · the
ﬂuorescence emitted at 420 nm and the x-axes represent min-
utes after injection of sample. The areas under the curves to the
dashed lines (above double arrowhead) were used to determine
the amount of labeled N-glycan based upon the value observed
for a known quantity of labeled NA2F. pKLK4, pig KLK4;
mKLK4, mouse KLK4; rhKLK4, recombinant human KLK4.
Fig. 2. Sialidation of N-glycans. The y-axes represent ﬂuores-
cence emitted at 420 nm and the x-axes represent minutes from
injection of sample. (A) Normal-phase high-performance liquid
chromatography (NP-HPLC) chromatograms of glycan stan-
dards containing no (NA2), one (A1), two (A2) and three (A3)
sialic acid attachments.(B) NP-HPLC chromatograms of
labeled N-glycans released from pig (left) or mouse (right)
kallikrein-related peptidase 4 (KLK4). Arrows point to the
retention times of the standards. Note that the N-glycans re-
leased from mouse KLK4 do not show peaks at retention times
for three sialic acids.
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variably glycosylated with NA2 and NA2F biantennary
structures, use a similar triantennary structure (pig NA3;
mouse Na3F), and are heterogeneous in their sialic acid
contents. Pig and mouse KLK4 both migrate as doublets
on SDS-PAGE, but the apparent molecular mass of pig
KLK4 is higher (Fig. 1B), suggesting that it is more gly-
cosylated than mouse KLK4. Pig and mouse KLK4 both
have three potential N-glycosylation sites, two of which
are at homologous positions (Asn139 and Asn184). Our
working hypothesis is that pig KLK4 can be glycosylated
at all three sites, but that mouse KLK4 is glycosylated at
only two, presumably at the two N-glycan attachment
sites that are homologous with pig KLK4.
Human KLK4 has never been isolated from natural
sources, so it is not known if it is glycosylated.
Recombinant forms of human KLK4 have been
characterized. Human KLK4 expressed in bacteria has a
trypsin-like speciﬁcity with a strong preference for Arg at
the P1 position of its substrates (18) and is inhibited by
zinc (8). These ﬁndings diﬀer from our experience with
pig KLK4, which cleaves amelogenin (its natural
substrate) at many sites. Among the 10 sites we charac-
terized, only one was after arginine and one was after
lysine (9). Porcine KLK4 was also active in the presence
of zinc (data not shown). The commercially available
recombinant human KLK4 did not appear to be gly-
cosylated and seemed to lose activity rapidly compared
with the glycosylated pig and mouse enzymes from in vivo
sources. Because the pig and mouse enzymes lose activity
as they are deglycosylated, it seems likely that glycosyl-
ation is important for KLK4 stability, presumably by
protecting it from proteolytic degradation. The KLK4
tertiary fold is unlikely to depend upon glycosylation
Fig. 3. Characterization of desialylated N-glycan cores. The
y-axes represent ﬂuorescence emitted at 420 nm and the x-axes
represent minutes from injection of sample. (A) Normal-phase
high-performance liquid chromatography (NP-HPLC) chro-
matograms of labeled N-glycans following sialidase digestion.
(B) Reverse-phase high performance liquid chromatography
(RP-HPLC) chromatograms of biantennary (NA2 and NA2F)
and triantennary (NA3) N-glycan core standards and labeled
asialo N-glycan cores from pig and mouse kallikrein-related
peptidase 4 (KLK4). Note that peak a corresponds to the NA2
standard and peak c corresponds to the NA2F standard, and
that both N-glycan cores are found in pig and mouse KLK4.
Peak b corresponds to the NA3 standard, which is found in pig
KLK4 only. (C) RP-HPLC chromatograms of peak d before
and after a-(1-6)-fucosidase digestion. Note that removal of
fucose converts peak d into peak b, which corresponds to the
NA3 standard.
Fig. 4. (A) Chromatograms of monosaccharide standards and
labeled N-glycan cores a to d following their hydrolysis into
monosaccharides. The areas under each chromatographic peak
were calculated to determine the number of each monosac-
charide per N-glycan molecule. The y-axes represent ﬂuores-
cence emitted at 425 nm and the x-axes represent minutes from
injection of sample. Fuc, fucose; Gal, galactose; GalN, galac-
tosamine; GlcN, glucosamine; Man, mannose; R, reagent. (B)
Matrix-assisted laser desorption/ionization time-of-ﬂight mass
spectrometry (MALDI-TOF MS) results for 2-aminobenzoic
acid (2-AA)-labeled N-glycan cores a to d. The mass numbers
(x-axes) are in daltons. (C) Summary of glycan composition
and mass spectrometry analyses. Mass values were calculated
using GlycanMass on the ExPASy Proteomics Server (34). The
calculated mass for each N-glycan core corresponds closely
(within 0.32 Da) with the measured mass minus the mass of the
2-AA ﬂuorescent attachment (119.12 Da), which is the mass of
2-AA (137.14 Da) less water (18.02 Da).
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because it is stabilized by six disulﬁde bridges (10). We
speculate that human KLK4 is likely to be glycosylated at
Asn139, and that the glycosylated form of the enzyme will
show greater stability and broader substrate speciﬁcity
than the unglycosylated recombinant enzyme.
Glycosylation is an important feature of enamel
proteins. Dental enamel forms in a well-deﬁned extra-
cellular space, the contents of which are determined by
ameloblasts (19, 20). The major enamel proteins are
amelogenin, ameloblastin, and enamelin (21). The
enamel proteases are MMP20 and KLK4 (22, 23).
Amelogenin and MMP20 are not glycosylated. Amel-
oblastin has O-linked glycosylations on its N-terminal
(24) and C-terminal (25) domains, but has no N-linked
glycosylations. Enamelin and KLK4 are both N-gly-
cosylated. Enamelin and ameloblastin are expressed
during the secretory stage and are degraded by MMP20.
Their glycosylated domains preferentially accumulate in
the matrix. In the pig, the 186-kDa secreted enamelin is
degraded down to a 32-kDa cleavage product that is
resistant to further processing by MMP20 (26), and
accumulates to 1% of total enamel protein (27). Al-
though comprised of only 104 amino acids, the 32-kDa
enamelin is the most highly modiﬁed and conserved part
of the enamelin (28, 29). It has three N-linked glycosy-
lations and two phosphoserines (30, 31). The porcine
32-kDa enamelin has the same variably sialylated
biantennary structure (NA2F) as KLK4. It also has a
variably sialylated complex triantennary structure (G-
NGA3F), which diﬀers from the triantennary N-glycan
on KLK4.
Amelogenin has a tyrosyl motif in its primary amino
acid sequence that behaves like a lectin and binds Glc-
NAc (32). The ability of amelogenin to bind GlcNAc has
been proposed to mediate interactions between amelo-
genin and enamel glycoproteins. However, character-
ization of the N-glycosylations on enamelin and KLK4
showed that GlcNAc is never at the end of the N-glycan
chains where it is accessible for amelogenin binding.
Previously we demonstrated that the 32-kDa enamelin
does not bind amelogenin unless it is ﬁrst desialylated
and then digested with b-galactosidase to remove the
terminal b-galactose and expose GlcNAc at the N-glycan
surface (33). There is no known glycoprotein in dental
enamel with a superﬁcial GlcNAc, so the functional
signiﬁcance (if any) of amelogenin binding to this
monosaccharide is unknown.
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